IMARC Group

China Diabetes Market: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

Press Release   •   Dec 08, 2015 16:18 IST

As the second largest economy of the world, China enjoys pink of health but its affluence is giving rise to another sickness - a rapid increase in a life-style disease called diabetes. With the Chinese population getting richer, fatter and less mobile, there has been a surge in the prevalence of diabetes. With a prevalence rate of around 12 percent in the adult population, China currently represents the diabetes capital of the world.

The rising prevalence of diabetes, however, is catalysing the market for diabetes products in the country. Driven by a continuous economic growthand increasing disposable incomes, the diabetes market - Non-Insulin Anti-diabetics, Insulin and Diabetes Diagnostics is witnessing double digit growth rates and creating lucrative opportunities for global pharmaceutical and diagnostic companies at a time when growth rates in the more developed markets have declined.

IMARC’s new report “China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the china diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Chinese diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in China
  • Historical, current and future prevalence of type-1 and type-2 diabetes in China
  • Historical, current and future prevalence of diabetes in the urban and rural regions in China
  • Historical, current and future prevalence of diabetes among males and females in China
  • Historical, current and future prevalence of diabetes among various age groups in China
  • Historical, current and future diagnosis rates for diabetes in China
  • Historical, current and future drug treatment rates for diabetes in China

Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in China
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Chinese Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in China
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in China
  • Market segmentation
  • Key players
  • Market outlook

To know more about China Diabetes Market: http://www.imarcgroup.com/china-diabetes-market

Read More Reports on Diabetes Markethttp://www.imarcgroup.com/india-diabetes

Contact Us

IMARC Group

Email: Sales@imarcgroup.com

Website: http://www.imarcgroup.com/

Contact No: +91-120-415-5099

The International Market Analysis Research and Consulting Group is leading name in market research and strategy management. We provide assistance to our clients to address the most critical challenges and transform their business. We provide end to end solution for all sectors and customized according to requirement of clients. Company offer full range of market research service, data analytics solutions to clients combined with strong technology and process orientation. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Read More: http://www.imarcgroup.com/